Lipocalin-2 is upregulated in adipose tissues and the liver in obesity [51,91], and as lipocalin-2 decreases food intake and promotes fat cell browning, this indicates higher lipocalin-2 levels to counteract obesity and metabolic diseases [92,93]. Here, LCN2 is linked to metabolic disease.